(July 23, 2020, 12:09 PM EDT) -- NEW YORK — A whistleblower whose false claims lawsuit resulted in drug maker Novartis Pharmaceuticals Corp. agreeing to a $678 million settlement will receive 18.5 percent of the false claims portion of the settlement or $109.41 million, according to a stipulated order signed July 21 by a New York federal judge (United States, ex rel. Oswald Bilotta v. Novartis Pharmaceuticals Corp., No. 11-71, S.D. N.Y.)....